High risk lesions in Esophageal squamous cell carcinoma
Conditions
Interventions
Group 1 vs. Group 2:EndoAngel assisted esophagogastroscopy vs. conventional esophagogastroscopy
Sponsors
Renmin Hospital of Wuhan University
Eligibility
Sex/Gender
All
Age
50 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1) Male or female aged 50 years or above; 2) Able to read, understand and sign informed consent; 3) The investigator believes that subjects can understand the process of the clinical study, are willing and able to complete all the study procedures and follow-up visits, and cooperate with the study procedures.
Exclusion criteria
Exclusion criteria: 1) Patients with known esophageal cancer; 2) Patients with absolute contraindications to esophagogastroscopy; 3) Patients with contraindications to biopsy; 4) patients with esophageal surgery, radiotherapy, chemotherapy, radiotherapy or chemotherapy history; 5) Patients with suspected active upper gastrointestinal bleeding; 6) Pregnant or lactating women; 7) Patients with known or suspected upper gastrointestinal obstruction 8) Previous failed esophagogastroscopy; 9) High-risk diseases or other special conditions that the investigator considers the subject unsuitable for participation in the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| High Risk Lesion Detection Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Detection rate of high risk lesions in cervical, thoracic and abdominal segments of esophagus;Detection rate of advanced esophageal cancer;Detection rate of early esophageal cancer;Detection rate of precancerous lesions;Detection rate of low risk lesions;Adverse events (AES) and serious adverse events (SAEs); | — |
Countries
China
Contacts
Public ContactLi-Ping Ye
Zhejiang Province affiliated to Wenzhou Medical University
Outcome results
None listed